The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Neurology Digital Therapeutics-Global Market Insights and Sales Trends 2025
Synopsis
The global Neurology Digital Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Neurology Digital Therapeutics in various end use industries. The expanding demands from the Hospital, Clinics and Others,, are propelling Neurology Digital Therapeutics market. Software, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Devices segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Neurology Digital Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Neurology Digital Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Neurology Digital Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Neurology Digital Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Neurology Digital Therapeutics covered in this report include Livongo Health, Noom, Omada Health, Pear Therapeutics, WellDoc, Proteus Digital Health, Propeller Health, Akili Interactive Labs and Mango Health, etc.
The global Neurology Digital Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Livongo Health
Noom
Omada Health
Pear Therapeutics
WellDoc
Proteus Digital Health
Propeller Health
Akili Interactive Labs
Mango Health
Better Therapeutics
Happify
Kaia Health
Click Therapeutics
Global Neurology Digital Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Neurology Digital Therapeutics market, Segment by Type:
Software
Devices
Global Neurology Digital Therapeutics market, by Application
Hospital
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Neurology Digital Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Neurology Digital Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Neurology Digital Therapeutics in various end use industries. The expanding demands from the Hospital, Clinics and Others,, are propelling Neurology Digital Therapeutics market. Software, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Devices segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Neurology Digital Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Neurology Digital Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Neurology Digital Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Neurology Digital Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Neurology Digital Therapeutics covered in this report include Livongo Health, Noom, Omada Health, Pear Therapeutics, WellDoc, Proteus Digital Health, Propeller Health, Akili Interactive Labs and Mango Health, etc.
The global Neurology Digital Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Livongo Health
Noom
Omada Health
Pear Therapeutics
WellDoc
Proteus Digital Health
Propeller Health
Akili Interactive Labs
Mango Health
Better Therapeutics
Happify
Kaia Health
Click Therapeutics
Global Neurology Digital Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Neurology Digital Therapeutics market, Segment by Type:
Software
Devices
Global Neurology Digital Therapeutics market, by Application
Hospital
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Neurology Digital Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Neurology Digital Therapeutics
1.1 Neurology Digital Therapeutics Market Overview
1.1.1 Neurology Digital Therapeutics Product Scope
1.1.2 Neurology Digital Therapeutics Market Status and Outlook
1.2 Global Neurology Digital Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Neurology Digital Therapeutics Market Size by Region (2018-2029)
1.4 Global Neurology Digital Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Neurology Digital Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Neurology Digital Therapeutics Market Size (2018-2029)
1.6.1 North America Neurology Digital Therapeutics Market Size (2018-2029)
1.6.2 Europe Neurology Digital Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Neurology Digital Therapeutics Market Size (2018-2029)
1.6.4 Latin America Neurology Digital Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Neurology Digital Therapeutics Market Size (2018-2029)
2 Neurology Digital Therapeutics Market by Type
2.1 Introduction
2.1.1 Software
2.1.2 Devices
2.2 Global Neurology Digital Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Neurology Digital Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Neurology Digital Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Neurology Digital Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Neurology Digital Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Neurology Digital Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Neurology Digital Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Neurology Digital Therapeutics Revenue Breakdown by Type (2018-2029)
3 Neurology Digital Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinics
3.1.3 Others
3.2 Global Neurology Digital Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Neurology Digital Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Neurology Digital Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Neurology Digital Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Neurology Digital Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Neurology Digital Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Neurology Digital Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Neurology Digital Therapeutics Revenue Breakdown by Application (2018-2029)
4 Neurology Digital Therapeutics Competition Analysis by Players
4.1 Global Neurology Digital Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neurology Digital Therapeutics as of 2022)
4.3 Date of Key Players Enter into Neurology Digital Therapeutics Market
4.4 Global Top Players Neurology Digital Therapeutics Headquarters and Area Served
4.5 Key Players Neurology Digital Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Neurology Digital Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Livongo Health
5.1.1 Livongo Health Profile
5.1.2 Livongo Health Main Business
5.1.3 Livongo Health Neurology Digital Therapeutics Products, Services and Solutions
5.1.4 Livongo Health Neurology Digital Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Livongo Health Recent Developments
5.2 Noom
5.2.1 Noom Profile
5.2.2 Noom Main Business
5.2.3 Noom Neurology Digital Therapeutics Products, Services and Solutions
5.2.4 Noom Neurology Digital Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Noom Recent Developments
5.3 Omada Health
5.3.1 Omada Health Profile
5.3.2 Omada Health Main Business
5.3.3 Omada Health Neurology Digital Therapeutics Products, Services and Solutions
5.3.4 Omada Health Neurology Digital Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Pear Therapeutics Recent Developments
5.4 Pear Therapeutics
5.4.1 Pear Therapeutics Profile
5.4.2 Pear Therapeutics Main Business
5.4.3 Pear Therapeutics Neurology Digital Therapeutics Products, Services and Solutions
5.4.4 Pear Therapeutics Neurology Digital Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Pear Therapeutics Recent Developments
5.5 WellDoc
5.5.1 WellDoc Profile
5.5.2 WellDoc Main Business
5.5.3 WellDoc Neurology Digital Therapeutics Products, Services and Solutions
5.5.4 WellDoc Neurology Digital Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 WellDoc Recent Developments
5.6 Proteus Digital Health
5.6.1 Proteus Digital Health Profile
5.6.2 Proteus Digital Health Main Business
5.6.3 Proteus Digital Health Neurology Digital Therapeutics Products, Services and Solutions
5.6.4 Proteus Digital Health Neurology Digital Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Proteus Digital Health Recent Developments
5.7 Propeller Health
5.7.1 Propeller Health Profile
5.7.2 Propeller Health Main Business
5.7.3 Propeller Health Neurology Digital Therapeutics Products, Services and Solutions
5.7.4 Propeller Health Neurology Digital Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Propeller Health Recent Developments
5.8 Akili Interactive Labs
5.8.1 Akili Interactive Labs Profile
5.8.2 Akili Interactive Labs Main Business
5.8.3 Akili Interactive Labs Neurology Digital Therapeutics Products, Services and Solutions
5.8.4 Akili Interactive Labs Neurology Digital Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Akili Interactive Labs Recent Developments
5.9 Mango Health
5.9.1 Mango Health Profile
5.9.2 Mango Health Main Business
5.9.3 Mango Health Neurology Digital Therapeutics Products, Services and Solutions
5.9.4 Mango Health Neurology Digital Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Mango Health Recent Developments
5.10 Better Therapeutics
5.10.1 Better Therapeutics Profile
5.10.2 Better Therapeutics Main Business
5.10.3 Better Therapeutics Neurology Digital Therapeutics Products, Services and Solutions
5.10.4 Better Therapeutics Neurology Digital Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Better Therapeutics Recent Developments
5.11 Happify
5.11.1 Happify Profile
5.11.2 Happify Main Business
5.11.3 Happify Neurology Digital Therapeutics Products, Services and Solutions
5.11.4 Happify Neurology Digital Therapeutics Revenue (US$ Million) & (2018-2023)
5.11.5 Happify Recent Developments
5.12 Kaia Health
5.12.1 Kaia Health Profile
5.12.2 Kaia Health Main Business
5.12.3 Kaia Health Neurology Digital Therapeutics Products, Services and Solutions
5.12.4 Kaia Health Neurology Digital Therapeutics Revenue (US$ Million) & (2018-2023)
5.12.5 Kaia Health Recent Developments
5.13 Click Therapeutics
5.13.1 Click Therapeutics Profile
5.13.2 Click Therapeutics Main Business
5.13.3 Click Therapeutics Neurology Digital Therapeutics Products, Services and Solutions
5.13.4 Click Therapeutics Neurology Digital Therapeutics Revenue (US$ Million) & (2018-2023)
5.13.5 Click Therapeutics Recent Developments
6 North America
6.1 North America Neurology Digital Therapeutics Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Neurology Digital Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Neurology Digital Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Neurology Digital Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Neurology Digital Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Neurology Digital Therapeutics Market Dynamics
11.1 Neurology Digital Therapeutics Industry Trends
11.2 Neurology Digital Therapeutics Market Drivers
11.3 Neurology Digital Therapeutics Market Challenges
11.4 Neurology Digital Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
